CSPC Pharmaceutical expands share award scheme with new share purchase

CSPC Pharmaceutical Group Limited announced an on-market purchase of 6,000,000 shares on October 14, 2025. These shares will be held in trust for selected participants under its Restricted Share Award Scheme and represent approximately 0.052% of the company's existing total shares in issue.

The shares were acquired at an average price of HK$8.8436 per share, totaling a consideration of approximately HK$53,062,000. Following this purchase, the balance of shares held by the Trustee for the scheme now stands at 109,000,000 shares.

The company's board will continue to review and determine the number of shares to be awarded to selected participants and the extent of future on-market purchases under the scheme at its discretion. The Share Award Scheme was initially adopted on August 20, 2018, with terms subsequently amended on May 21, 2024.